191 Publications (Page 2 of 8)
2019
Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host DiseaseAgrawal, Vaibhav⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Griffin, Shawn P⋅Griffin, Shawn P⋅Griffin, Shawn P⋅Griffin, Shawn P⋅Koch, Lindsey⋅Koch, Lindsey⋅Koch, Lindsey⋅Koch, Lindsey⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Ervin, Kirsten D⋅Ervin, Kirsten D⋅Ervin, Kirsten D⋅Ervin, Kirsten D⋅Schmidt, Caitlin A⋅Schmidt, Caitlin A⋅Schmidt, Caitlin A⋅Schmidt, Caitlin A⋅Cox, Elizabeth A⋅Cox, Elizabeth A⋅Cox, Elizabeth A⋅Cox, Elizabeth A⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Brinda, Bryan J⋅Brinda, Bryan J⋅Brinda, Bryan J⋅Brinda, Bryan J⋅Nelson, Robert P⋅Nelson, Robert P⋅Nelson, Robert P⋅Nelson, Robert P⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu and Zaid, Mohammad AbuBiology of Blood and Marrow Transplantation, vol. 25, (no. 3), pp. S250, March 2019.
| Journal Article
Prognostic value of serum tumor marker (STM) rate of decline during high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT) for relapsed germ-cell tumors (rGCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e16044, 2019-05-20.
| Journal Article
Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational StudyHungria, Vania T.M⋅Lee, Hans C⋅Abonour, Rafat⋅Rifkin, Robert M⋅Terpos, Evangelos⋅Leleu, Xavier⋅Costello, Caitlin L⋅van Rhee, Frits⋅Weisel, Katja C⋅Puig, Noemi⋅Berdeja, Jesus G⋅Cook, Gordon⋅Usmani, Saad Z⋅Thompson, Michael A⋅Boccadoro, Mario⋅Zonder, Jeffrey A⋅Spencer, Andrew⋅Hajek, Roman⋅Fanning, Suzanne R⋅Boyd, Kevin⋅Omel, Jim⋅Armour, Mira⋅Morgan, Kathryn E⋅Patel, Ronak S⋅Carlson, Gary L⋅Ferrari, Renda H⋅Stull, Dawn Marie⋅Ren, Kaili⋅Cherepanov, Dasha⋅Pottala, James V and Chari, AjaiBlood, vol. 134, (no. Supplement_1), pp. 1887, 2019-11-13.
| Journal Article
Risk factors for renal failure (RF) during high-dose chemotherapy (HDCT) and outcomes for patients (pts) with relapsed germ-cell tumors (rGCT)Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e16042, 2019-05-20.
| Journal Article
Survival and toxicity outcomes in patients age 40 or older with relapsed metastatic germ cell tumors (mGCT) treated with high-dose chemotherapy (HDCT) and autologous peripheral-blood stem cell transplant (PBSCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 37, (no. 7_suppl), pp. 522, 2019-03-01.
| Journal Article
Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect® MM RegistryLee, Hans C⋅Ailawadhi, Sikander⋅Gasparetto, Cristina⋅Jagannath, Sundar⋅Rifkin, Robert M⋅Durie, Brian G.M⋅Narang, Mohit⋅Terebelo, Howard R⋅Toomey, Kathleen⋅Hardin, James W⋅Wagner, Lynne I⋅Omel, James L⋅Srinivasan, Shankar⋅Liu, Liang⋅Dhalla, Mazaher⋅Agarwal, Amit and Abonour, RafatBlood, vol. 134, (no. Supplement_1), pp. 3129, 2019-11-13.
| Journal Article
2018
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM StudyCostello, Caitlin⋅Costello, Caitlin⋅Boccadoro, Mario⋅Boccadoro, Mario⋅Usmani, Saad Z⋅Usmani, Saad Z⋅Chari, Ajai⋅Chari, Ajai⋅Rifkin, Robert M⋅Rifkin, Robert M⋅Abonour, Rafat⋅Abonour, Rafat⋅Berdeja, Jesus⋅Berdeja, Jesus⋅Cook, Gordon⋅Cook, Gordon⋅Goldschmidt, Hartmut⋅Goldschmidt, Hartmut⋅Hajek, Roman⋅Hajek, Roman⋅Hungria, Vania⋅Hungria, Vania⋅Lee, Hans C⋅Lee, Hans C⋅Leleu, Xavier⋅Leleu, Xavier⋅Omel, Jim⋅Omel, Jim⋅Spencer, Andrew⋅Spencer, Andrew⋅Thompson, Michael A⋅Thompson, Michael A⋅Vela-Ojeda, Jorge⋅Vela-Ojeda, Jorge⋅Zonder, Jeffrey A⋅Zonder, Jeffrey A⋅Puig, Noemi⋅Puig, Noemi⋅Aguarón, Alfonso⋅Aguarón, Alfonso⋅Davies, Faith E⋅Davies, Faith E⋅Demers, Brittany⋅Demers, Brittany⋅Ren, Kaili⋅Ren, Kaili⋅Yu, Shawn⋅Yu, Shawn⋅Skacel, Tomas⋅Skacel, Tomas⋅Stull, Dawn Marie⋅Stull, Dawn Marie⋅Terpos, Evangelos and Terpos, EvangelosClinical Lymphoma Myeloma and Leukemia, vol. 18, pp. S248, 2018-09-00.
| Journal Article
Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patientsAdams, Rebecca⋅Adams, Rebecca⋅Adams, Rebecca N⋅Adams, Rebecca⋅Adams, Rebecca⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine⋅Mosher, Catherine E⋅Winger, Joseph G⋅Winger, Joseph⋅Winger, Joseph⋅Winger, Joseph⋅Winger, Joseph⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Kroenke, Kurt⋅Kroenke, Kurt⋅Kroenke, Kurt⋅Kroenke, Kurt and Kroenke, KurtJournal of Behavioral Medicine, vol. 41, (no. 2), pp. 252, 20180400.
| Journal Article
Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016)Jagannath, Sundar⋅Abonour, Rafat⋅Durie, Brian G.M⋅Gasparetto, Cristina⋅Hardin, James W⋅Narang, Mohit⋅Terebelo, Howard R⋅Toomey, Kathleen⋅Wagner, Lynne⋅Srinivasan, Shankar⋅Kitali, Amani⋅Yue, Lihua⋅Flick, E.Dawn⋅Agarwal, Amit and Rifkin, Robert MClinical Lymphoma, Myeloma and Leukemia, vol. 18, (no. 7), pp. 485.e3, July 2018.
| Journal Article
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MMJagannath, Sundar⋅Jagannath, Sundar⋅Abonour, Rafat⋅Abonour, Rafat⋅Durie, Brian G M⋅Durie, Brian G M⋅Narang, Mohit⋅Narang, Mohit⋅Terebelo, Howard R⋅Terebelo, Howard R⋅Gasparetto, Cristina J⋅Gasparetto, Cristina J⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Hardin, James W⋅Hardin, James W⋅Wagner, Lynne⋅Wagner, Lynne⋅Agarwal, Amit⋅Agarwal, Amit⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Kitali, Amani⋅Kitali, Amani⋅Flick, E Dawn⋅Flick, E Dawn⋅Sturniolo, Michael⋅Sturniolo, Michael⋅Rifkin, Robert M and Rifkin, Robert MBlood advances, vol. 2, (no. 13), pp. 1615, 2018-07-10.
| Journal Article
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM RegistryAbonour, Rafat⋅Abonour, Rafat⋅Wagner, Lynne⋅Wagner, Lynne⋅Durie, Brian G M⋅Durie, Brian⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Narang, Mohit⋅Narang, Mohit⋅Terebelo, Howard⋅Terebelo, Howard R⋅Gasparetto, Cristina⋅Gasparetto, Cristina J⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Hardin, James⋅Hardin, James W⋅Kitali, Amani⋅Kitali, Amani⋅Gibson, Craig⋅Gibson, Craig J⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Swern, Arlene S⋅Swern, Arlene⋅Rifkin, Robert M and Rifkin, RobertAnnals of Hematology, vol. 97, (no. 12), pp. 2436, 20181200.
| Journal Article
Overall Survival of Patients Post-Transplant: Study Results from Two Phase 3 Trials ASPIRE and ENDEAVORGoldschmidt, Hartmut⋅Mateos, Maria-Victoria⋅Siegel, David⋅Abonour, Rafat⋅Ludwig, Heinz⋅Obreja, Mihaela⋅Iskander, Karim Saad and Hari, ParameswaranClinical Lymphoma Myeloma and Leukemia, vol. 18, pp. S239, 2018-09-00.
| Journal Article
Predictors of long-term survival in newly diagnosed multiple myeloma (NDMM) patients (pts) enrolled in the Connect MM registryGasparetto, Cristina⋅Rifkin, Robert M⋅Terebelo, Howard R⋅Toomey, Kathleen⋅Durie, Brian G⋅Hardin, James W⋅Jagannath, Sundar⋅Wagner, Lynne I⋅Narang, Mohit⋅Ailawadhi, Sikander⋅Flick, E. Dawn⋅Kotey, Stanley⋅Srinivasan, Shankar⋅Kitali, Amani⋅Agarwal, Amit and Abonour, RafatJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 8037, 2018-05-20.
| Journal Article
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple MyelomaVogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Cornell, Robert Frank⋅Cornell, Robert Frank⋅Cornell, Robert Frank⋅Cornell, Robert Frank⋅Cornell, Robert Frank⋅Cornell, Robert Frank⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Bhutani, Divaya⋅Bhutani, Divaya⋅Bhutani, Divaya⋅Bhutani, Divaya⋅Bhutani, Divaya⋅Bhutani, Divaya⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Nooka, Ajay⋅Nooka, Ajay⋅Nooka, Ajay⋅Nooka, Ajay⋅Nooka, Ajay⋅Nooka, Ajay⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Cole, Craig⋅Cole, Craig⋅Cole, Craig⋅Cole, Craig⋅Cole, Craig⋅Cole, Craig⋅Vij, Ravi⋅Vij, Ravi⋅Vij, Ravi⋅Vij, Ravi⋅Vij, Ravi⋅Vij, Ravi⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Schiller, Gary⋅Schiller, Gary⋅Schiller, Gary⋅Schiller, Gary⋅Schiller, Gary⋅Schiller, Gary⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Costa, Luciano J⋅Costa, Luciano J⋅Costa, Luciano J⋅Costa, Luciano J⋅Costa, Luciano J⋅Costa, Luciano J⋅Kaminetzky, David⋅Kaminetzky, David⋅Kaminetzky, David⋅Kaminetzky, David⋅Kaminetzky, David⋅Kaminetzky, David⋅Hoffman, James E⋅Hoffman, James E⋅Hoffman, James E⋅Hoffman, James E⋅Hoffman, James E⋅Hoffman, James E⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Fonseca, Rafael⋅Fonseca, Rafael⋅Fonseca, Rafael⋅Fonseca, Rafael⋅Fonseca, Rafael⋅Fonseca, Rafael⋅Van Wier, Scott⋅Van Wier, Scott⋅Van Wier, Scott⋅Van Wier, Scott⋅Van Wier, Scott⋅Van Wier, Scott⋅Ahmann, Gregory⋅Ahmann, Gregory⋅Ahmann, Gregory⋅Ahmann, Gregory⋅Ahmann, Gregory⋅Ahmann, Gregory⋅Lopez, Ilsel⋅Lopez, Ilsel⋅Lopez, Ilsel⋅Lopez, Ilsel⋅Lopez, Ilsel⋅Lopez, Ilsel⋅Kauffman, Michael⋅Kauffman, Michael⋅Kauffman, Michael⋅Kauffman, Michael⋅Kauffman, Michael⋅Kauffman, Michael⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Saint-Martin, Jean-Richard⋅Saint-Martin, Jean-Richard⋅Saint-Martin, Jean-Richard⋅Saint-Martin, Jean-Richard⋅Saint-Martin, Jean-Richard⋅Saint-Martin, Jean-Richard⋅Picklesimer, Carla D⋅Picklesimer, Carla D⋅Picklesimer, Carla D⋅Picklesimer, Carla D⋅Picklesimer, Carla D⋅Picklesimer, Carla D⋅Choe-Juliak, Cassandra⋅Choe-Juliak, Cassandra⋅Choe-Juliak, Cassandra⋅Choe-Juliak, Cassandra⋅Choe-Juliak, Cassandra⋅Choe-Juliak, Cassandra⋅Stewart, A Keith⋅Stewart, A Keith⋅Stewart, A Keith⋅Stewart, A Keith⋅Stewart, A Keith and Stewart, A KeithJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 36, (no. 9), pp. 866, 2018-03-20.
| Journal Article
Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational StudyUsmani, Saad Z⋅Hungria, Vania T. M⋅Leleu, Xavier⋅Lee, Hans C⋅Davies, Faith E⋅Costello, Caitlin L⋅Rifkin, Robert M⋅Weisel, Katja⋅Chari, Ajai⋅Puig, Noemi⋅Boccadoro, Mario⋅Cook, Gordon⋅Berdeja, Jesus G⋅Zonder, Jeffrey A⋅Thompson, Michael A⋅Abonour, Rafat⋅Vela-Ojeda, Jorge⋅Hajek, Roman⋅Spencer, Andrew⋅Omel, Jim⋅Demers, Brittany⋅Romanus, Dorothy⋅Ren, Kaili⋅Skacel, Tomas⋅Stull, Dawn Marie and Terpos, EvangelosBlood, vol. 132, (no. Supplement 1), pp. 3289, 2018-11-29.
| Journal Article
Treatment Choices and Outcomes for Patients with Multiple Myeloma after Relapse on Lenalidomide Maintenance Therapy: Results from the Connect® MM RegistryJagannath, Sundar⋅Jagannath, Sundar⋅Narang, Mohit⋅Narang, Mohit⋅Ailawadhi, Sikander⋅Ailawadhi, Sikander⋅Rifkin, Robert M⋅Rifkin, Robert M⋅Terebelo, Howard R⋅Terebelo, Howard R⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Durie, Brian GM⋅Durie, Brian GM⋅Hardin, James W⋅Hardin, James W⋅Gasparetto, Cristina J⋅Gasparetto, Cristina J⋅Wagner, Lynne⋅Wagner, Lynne⋅Omel, James⋅Omel, James⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Kitali, Amani⋅Kitali, Amani⋅Agarwal, Amit⋅Agarwal, Amit⋅Abonour, Rafat and Abonour, RafatBlood, vol. 132, (no. Supplement 1), pp. 3232, 2018-11-29.
| Journal Article
Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM RegistryRifkin, Robert M⋅Rifkin, Robert M⋅Rifkin, Robert M.⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Durie, Brian G.M.⋅Durie, Brian G M⋅Durie, Brian G.M⋅Narang, Mohit⋅Narang, Mohit⋅Narang, Mohit⋅Terebelo, Howard R.⋅Terebelo, Howard R⋅Terebelo, Howard R⋅Gasparetto, Cristina J⋅Gasparetto, Cristina J⋅Gasparetto, Cristina J.⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Hardin, James W⋅Hardin, James W⋅Hardin, James W.⋅Wagner, Lynne⋅Wagner, Lynne⋅Wagner, Lynne⋅Parikh, Kejal⋅Parikh, Kejal⋅Parikh, Kejal⋅Abouzaid, Safiya⋅Abouzaid, Safiya⋅Abouzaid, Safiya⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Kitali, Amani⋅Kitali, Amani⋅Kitali, Amani⋅Zafar, Faiza⋅Zafar, Faiza⋅Zafar, Faiza⋅Abonour, Rafat⋅Abonour, Rafat and Abonour, RafatClinical Therapeutics, vol. 40, (no. 7), pp. 1202.e1, July 2018.
| Journal Article
Treatment (tx) journeys in newly diagnosed multiple myeloma (NDMM) patients (pts): Results from the Connect MM RegistryJagannath, Sundar⋅Rifkin, Robert M⋅Gasparetto, Cristina⋅Toomey, Kathleen⋅Durie, Brian G⋅Hardin, James W⋅Terebelo, Howard R⋅Wagner, Lynne I⋅Narang, Mohit⋅Ailawadhi, Sikander⋅Srinivasan, Shankar⋅YoussefAgha, Ahmed⋅Ung, Brian⋅Kitali, Amani⋅Flick, E. Dawn⋅Agarwal, Amit and Abonour, RafatJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 8041, 2018-05-20.
| Journal Article
2017
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.Vadhan-Raj, Saroj⋅Vadhan-Raj, Saroj⋅Abonour, Rafat⋅Abonour, Rafat⋅Goldman, Jonathan W⋅Goldman, Jonathan W⋅Smith, David A⋅Smith, David A⋅Slapak, Christopher A⋅Slapak, Christopher A⋅Ilaria, Robert L⋅Ilaria, Robert L⋅Tiu, Ramon V⋅Tiu, Ramon V⋅Wang, Xuejing⋅Wang, Xuejing⋅Callies, Sophie⋅Callies, Sophie⋅Cox, Joanne⋅Cox, Joanne⋅Tuttle, Jay L⋅Tuttle, Jay L⋅Lau, Yiu-Keung⋅Lau, Yiu-Keung⋅Roeland, Eric J and Roeland, Eric JJournal of hematology & oncology, vol. 10, (no. 1), pp. 73, March 21, 2017.
| Journal Article
Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.Shah, Jatin J⋅Abonour, Rafat⋅Gasparetto, Christina⋅Hardin, James W⋅Toomey, Kathleen⋅Narang, Mohit⋅Srinivasan, Shankar⋅Kitali, Amani⋅Zafar, Faiza⋅Flick, E Dawn and Rifkin, Robert MClinical lymphoma, myeloma & leukemia, vol. 17, (no. 9), pp. 575-583.e2, September 2017.
| Journal Article
Health-Related Quality of Life (HRQoL) of Patients (pts) With Newly Diagnosed Multiple Myeloma (NDMM) Receiving Any or Lenalidomide (LEN) Maintenance After Autologous Stem Cell Transplant (ASCT) in the Connect® MM Disease RegistryAbonour, Rafat⋅Durie, Brian⋅Jagannath, Sundar⋅Shah, Jatin⋅Narang, Mohit⋅Terebelo, Howard⋅Gasparetto, Cristina⋅Toomey, Kathleen⋅Hardin, James⋅Kitali, Amani⋅Gibson, Craig⋅Srinivasan, Shankar⋅Swern, Arlene and Rifkin, RobertClinical Lymphoma, Myeloma & Leukemia, vol. 17, (no. 1), pp. e90, 2017.
| Journal Article
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University ExperienceAdra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 35, (no. 10), pp. 1102, 2017-Apr-01.
| Journal Article
High-dose chemotherapy (HDCT) plus peripheral-blood stem-cell transplant (PBSCT) for patients (pts) with relapsed germ-cell tumors (GCT) and active brain metastases (mets)Kalra, Maitri⋅Kalra, Maitri⋅Kalra, Maitri⋅Kalra, Maitri⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Mckay, John⋅Mckay, John⋅Mckay, John⋅Mckay, John⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 4558, 2017-05-20.
| Journal Article
High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantationFarag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S.⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Cairo, Mitchell S⋅Cairo, Mitchell S⋅Cairo, Mitchell S⋅Cairo, Mitchell S⋅Cairo, Mitchell S⋅Cairo, Mitchell S⋅Cairo, Mitchell S⋅Cairo, Mitchell S.⋅O’Leary, Heather A.⋅O'Leary, Heather A⋅O'Leary, Heather A⋅O'Leary, Heather A⋅O'Leary, Heather A⋅O'Leary, Heather A⋅O'Leary, Heather A⋅O'Leary, Heather A⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Delgado, David⋅Delgado, David⋅Delgado, David⋅Delgado, David⋅Delgado, David⋅Delgado, David⋅Delgado, David⋅Delgado, David⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Broxmeyer, Hal⋅Broxmeyer, Hal⋅Broxmeyer, Hal⋅Broxmeyer, Hal⋅Broxmeyer, Hal⋅Broxmeyer, Hal⋅Broxmeyer, Hal and Broxmeyer, HalOncotarget, vol. 8, (no. 66), pp. 110357, 2017-Dec-15.
| Journal Article
Impact of post-autologous stem cell transplant (ASCT) maintenance therapy on outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) using the large prospective community-based Connect MM registryJagannath, Sundar⋅Jagannath, Sundar⋅Abonour, Rafat⋅Abonour, Rafat⋅Durie, Brian G⋅Durie, Brian G.⋅Shah, Jatin J⋅Shah, Jatin J.⋅Narang, Mohit⋅Narang, Mohit⋅Terebelo, Howard R.⋅Terebelo, Howard R⋅Gasparetto, Cristina⋅Gasparetto, Cristina⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Hardin, James W.⋅Hardin, James W⋅Wagner, Lynne I⋅Wagner, Lynne I.⋅Agarwal, Amit⋅Agarwal, Amit⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Kitali, Amani⋅Kitali, Amani⋅Zafar, Faiza⋅Zafar, Faiza⋅Sturniolo, Michael⋅Sturniolo, Michael⋅Rifkin, Robert M and Rifkin, Robert M.Journal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 8040, 2017-05-20.
| Journal Article